Pierre Triozzi to Neovascularization, Pathologic
This is a "connection" page, showing publications Pierre Triozzi has written about Neovascularization, Pathologic.
Connection Strength
1.018
-
Brenner AJ, Cohen YC, Breitbart E, Bangio L, Sarantopoulos J, Giles FJ, Borden EC, Harats D, Triozzi PL. Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors. Clin Cancer Res. 2013 Jul 15; 19(14):3996-4007.
Score: 0.439
-
Triozzi PL, Borden EC. VB-111 for cancer. Expert Opin Biol Ther. 2011 Dec; 11(12):1669-76.
Score: 0.395
-
Triozzi PL, Achberger S, Aldrich W, Singh AD, Grane R, Borden EC. The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon. J Transl Med. 2012 Dec 05; 10:241.
Score: 0.107
-
Triozzi PL, Eng C, Singh AD. Targeted therapy for uveal melanoma. Cancer Treat Rev. 2008 May; 34(3):247-58.
Score: 0.077